News
Professor Jonathan Sterne presents to US Food and Drug Administration on COVID-19 boosters
Professor Jonathan Sterne, Deputy Director of the National Institute for Health Research Bristol Biomedical Research Centre (NIHR Bristol BRC), has presented evidence to the US Food and Drug Administration (FDA) on COVID-19 vaccination boosters today, Friday 17 September. The presentation is part of the FDA’s advisory committee meeting to discuss…
New population-wide health data resource to accelerate research on COVID-19 and cardiovascular disease in England
For the first time, a new linked health data resource covering 54.4 million people – over 96 per cent of the English population – is now available for researchers from across the UK to collaborate in NHS Digital’s secure research environment. This resource will enable vital research to take place…
NIHR Bristol BRC to benefit from internship programme to tackle underrepresentation of Black people in science
The National Institute for Health Research Bristol Biomedical Research Centre (NIHR Bristol BRC), a partnership between the University of Bristol and University Hospitals Bristol and Weston NHS Foundation Trust (UHBW), will host intern Angel Obierozie this summer as part of the Health Data Research UK (HDR UK) programme to…
Young people co-create COVID school study animation with researchers
As most pupils have now returned to school following lockdown, the COVID-19 school study, run by University of Bristol researchers, has also resumed fully. The study (also known as CoMMinS) aims to test thousands of pupils and staff for infection, in participating primary and secondary schools across Bristol. The…
Bristol researchers to collaborate on national study to understand long COVID
What is long COVID and how can diagnosis be improved? Using data from electronic health records at a national scale alongside information from thousands of participants in the UK’s population-based cohort studies, these and other questions will be tackled following an announcement on 18 February of a nationwide long COVID…
Genetic study of proteins is a breakthrough in drug development for complex diseases
An innovative genetic study of blood protein levels, led by researchers in the MRC Integrative Epidemiology Unit (MRC-IEU) at the University of Bristol, has demonstrated how genetic data can be used to support drug target prioritisation by identifying the causal effects of proteins on diseases. Working in collaboration with…
Analysis of seven trials finds that corticosteroids reduce risk of death by 20 per cent in critically ill COVID-19 patients
Corticosteroids reduce the risk of death among critically ill COVID-19 patients by 20 per cent, an analysis of seven trials published today [2 September] in the Journal of the American Medical Association (JAMA) has found. The results of three of the trials included in the meta-analysis are also published in…
Handgrip strength shown to identify people at high risk of type 2 diabetes
Findings demonstrate handgrip strength could be a cost-effective early screening tool A simple test such as the strength of your handgrip could be used as a quick, low-cost screening tool to help healthcare professionals identify patients at risk of type 2 diabetes. In new research, scientists at the universities of…
Implant choice more important than surgeon skill for hip replacement success
A study analysing over 650,000 hip replacement patients across England and Wales over 14 years sought to investigate why one hospital has consistently been identified as having better than expected outcomes compared to other settings. The findings have shown that the outstanding hip implant survival results seen in one centre…